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Association Between Serum Cholesterol and Chronic Kidney Disease
Differs by Gender Among Middle-aged and Elderly Chinese
D. W. Liu, Z. S. Liu, P. Wang
Department of Nephrology, The First Affiliated Hospital, Zhengzhou
University, Zhengzhou, China
Objectives: The association between hypercholesterolemia and CKD was
different in gender have been proved in animal experiments. In the current
study, we sought to investigate whether the mode of this association is
related to gender among Chinese population.
Methods: A total of 4779 middle-aged and elderly participants participated
in this study. CKD was defined as albuminuria and/or reduced estimated
glomerular filtration rate (eGFR) (<60 mL/min/1.73 m2). Regression analysis
was used to evaluate the association between serum cholesterol and albu-
minuria and reduced eGFR in females and males.
Results: The prevalence of hypercholesterolemia, albuminuria and reduced
eGFR was 10.7%, 6.4% and 2.8% in females and 12.7%, 6.9% and 2.3% in males,
respectively. The trends of prevalence of hypercholesterolemia and CKD indica-
tors were different between genders. Amongmales, the prevalence of albumin-
uria and reduced eGFR increased with age, and much higher prevalence of
hypercholesterolemia detected at both ends of the age spectrum. In females,
the prevalence both in CKD indicator and hypercholesterolemia was greater
for those in middle of the age spectrum. Hypercholesterolemia was associated
with CKD indicators [odds ratio (OR) 1.56, 95% confidence interval (CI),
1.01e2.42 for albuminuria and OR 2.29, 95% CI 1.31e3.98 for reduced eGFR,
respectively] only in females. Inmales, thefirst, second, third, and fourth serum
cholesterol quartiles were associated with albuminuria with an OR of 1 (refer-
ence), 1.80 (95% CI 1.01e3.14), 1.85 (95% CI 1.02e3.35), and 2.33 (95% CI
1.33e4.33), respectively.
Conclusion: Our findings indicated that the association between serum
cholesterol and CKD was different in gender among the middle-aged and
elderly Chinese population. Serum cholesterol had a graded association
with albuminuria in males.http://dx.doi.org/10.1016/j.hkjn.2015.09.144
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Cross-sectional Study on Use of Urinalysis for Screening Early Stage
Renal Dysfunction
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Background: Chronic kidney disease (CKD) has a high incidence and a poor prog-
nosis. Obvious signs and symptoms are absent at the early stage but proteinuria
and hematuria detected by routine urinalysis can indicate impaired renal func-
tion. The aim of this study was to evaluate the effect of routine urinalysis in
screening out patients with renal dysfunction at an early stage and to find asso-
ciated factors for CKD.1561-5413Methods: Healthy adults that received physical examination between Sep.
2008 and Sep. 2013 were enrolled in the study (n Z 43,516). Urine was
analyzed for protein, and red and white blood cells. 10 ml blood samples
were collected for serum creatinine, urea, albumin and other parameters
for the estimation of glomerular filtration rate.
Results: Abnormal routine urinalysis was found in 7.1% and renal dysfunction
was found in 0.9% of the enrolled subjects. Sensitivity for predicting renal
dysfunction was 0.110 and specificity was 0.928. The positive predictive
value was 0.014 and negative predictive value 0.986. Univariate analyses
of 6318 subjects suggested significant differences between the subjects
with renal dysfunction and normal subjects in terms of sex, age, smoking his-
tory, drinking history (all P < 0.001), history of malignancy (PZ 0.003), fam-
ily history of CKD (P Z 0.009), triglyceride (P Z 0.022), high density
lipoprotein (PZ 0.002), and apolipoprotein B (PZ 0.013). Multivariate anal-
ysis suggested significant associations of sex (P < 0.001, 95% CI
0.030e0.113), age (P < 0.001, 95% CI 1.027e1.064), and HDL (P Z 0.006,
95% CI 0.043e0.587) with renal dysfunction.
Conclusion: Routine urinalysis showed a poor performance in the screening
for early-stage renal insufficiency. Age, gender and HDL were associated
with renal dysfunction.http://dx.doi.org/10.1016/j.hkjn.2015.09.145
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Characteristics of Ambulatory Blood Pressure in CKD Patients with
Normal Causal Blood Pressure
Li SongYang
Jian Central Hospital, Shanghai, China
Objective: Evaluate the characteristics of ambulatory blood pressure in CKD
patients with normal causal blood pressure.
Methods: Selected 350 cases of CKD1-5 grade patients who had normal
causal blood pressure. Among them, 136 were male and 214 were female;
mean age was 62.65  14.2 years. The patients were into CKD normal blood
pressure group (146 cases) and elevated normal blood pressure group (204
cases). According to the levels of blood pressure, 50 healthy people were
in the control group. Kidney disease was the primary and secondary glomer-
ular diseases as well as renal tubular diseases. 24-hour blood pressure was
monitored with United States of Spacelab ambulatory blood pressure instru-
ments in these patients. The data was automatic analysis by software.
Results: Therewere120 caseswhohad the averageof ambulatory bloodpressure
increased. It was account for 34.3% in elevated normal blood pressure groups
whose 24-hour blood pressure and average diurnal blood pressure were signifi-
cantly higher than those control groups and CKD normal blood pressure groups
(P < 0.01). Masked hypertension (MHT) were 69 cases, the prevalence of MHT
was 19.7%. Abnormal blood pressure pattern (diurnal rhythm loss) was 58.6%
and in 205 cases, their blood pressure load were increased, it was account for
58.6%, the blood pressure load increased mainly at night.
Conclusion: Compared with causal blood pressure, the conditions of
abnormal blood pressure can be found by dynamic blood pressure but It
can be not found in consulting room, especially are in the night blood pres-
sure, the blood pressure load, the blood pressure pattern. These index are
Chronic Kidney Disease S107closely related to the target organ damage. It can be provided the basis for
the intervention of cardiovascular risk.http://dx.doi.org/10.1016/j.hkjn.2015.09.147
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Relationship Between Serum Level of Fibroblast Growth Factor-23
(FGF-23) and Calcium and Phosphate Metobolism of Patients with
Chronic Kidney Disease
Lyu Li, Wang Caili, Mi Yan
The First Affiliated Hospital of Baotou Medical College, Baotou, China
Objective: To investigate the relationship between serume level of fibro-
blast growth factor-23 (FGF-23) and calcium and phosphate of patients
with chronic kidney disease.
Methods: Intact FGF-23 and 1,25(OH)2 vitamin D3 were detected by enzyme-
linked immunosorbent assay (ELISA) in CKD 151 patients with various degree
of renal function and fourteen healthy controls, at the same time, some
other parameters including creatinine, serum phosphate, calcium, parathyr-
iod hormone, uric acid and alkaline phosphatese were measured. Further,
the relationship between FGF-23 and other biochemical variables was
analysed.
Results: (1) The level of serum FGF-23 was gradually elevated at CKD stage
1,2e3,4e5, there were significant difference in CKD stage 2e3 and 4e5
compared respectively with normal controls (P < 0.01), and in CKD stage
4e5 compared with CKD stage 1 and 2e3 (P < 0.01). (2) In the CKD stage
1e5 the level of serum FGF-23 by Pearson relativity analysis was significantly
correlated positively with creatinine (r Z 0.97, P < 0.01), phosphate
(r Z 0.65, P < 0.01), and parathyroid hormone (r Z 0.536, P < 0.01). The
level of serum FGF-23 by Pearson relativity analysis was significantly corre-
lated negatively with eGFR (r Z 0.578, P < 0.01), 1,25(OH)2 vitamin D3
(r Z 0.586, P < 0.01). (3) In the CKD stage 1e5, creatinine, 1,25(OH)2
vitamin D3 and parathyroid hormone were significant variables that influ-
enced the level of serum FGF-23 in multiple regression analysis.
Conclusion: FGF-23 concentrations were gradually elevated in three groups
of patients with CKD, serum phosphorus, 1,25(OH)2D3, intact PTH and creat-
inine are the major regulators that influenced FGF-23.0051
Table 2 151例CKD患者FGF-23与相关变量的相关分析
NZ 151 r-value P-value
CREA 0.971 <0.01
eGFR -0.578 <0.01
1.25(OH)2D3 -0.586 <0.01
Ca -0.327 <0.01
P 0.650 <0.01
Ca*P 0.477 <0.01
UA 0.173 0.033
ALP 0.143 0.079
PTH 0.536 <0.01http://dx.doi.org/10.1016/j.hkjn.2015.09.1480051
Table 1 CKD1-5期患者血清各指标的比较(x  s)
CREA eGFR FGF-23 1.25
(mmol/l) (ml/min/1.73 m2) (pg/ml) (pg/
正常对照组 43.8  2.71 118.81  5.42 20.82  1.20 595
NZ 14 (x  s)
CKD1期 69.82  13.20 112.62  8.18 71.19  8.26 546
NZ 22 (x  s)
CKD2-3期 139.90  35.19 58.97  16.96) 81.73  13.23) 531
NZ 47 (x  s)
CKD4-5期 440.74
 331.36)6
15.75
 7.67)6
198.05
 111.68)6
409
 1NZ 82 (x  s)
方差分析 F 28.67 593.98 38.46 19.9
P <0.01 <0.01 <0.01 <0.
*和对照组比较，P<0.05；6与CKD1、CKD2-3比较，P<0.05.0052
Function of Reduced Blood Pressure by Compound a-Ketoacid in Non-
dialysis Patients with CKD Stage 3e5
Li SongYang
Jinan Central Hospital, Shanghai, China
Objective: Evaluate the effect of blood pressure-lowering by a-ketoacid in
patients with CKD.
Methods: Selected non-dialysis patients who had hypertension of CKD 3e5
grade, except three cases. All of the patients had taken anti-hypertension
medicine over 3 months. They were treated for an average of 34.5  38.7
months, but SBP was still  140 mmHg and DBP  90 mmHg. A total of 102
patients were included in the statistical analysis. Among them, 61 were
male and 41 were female. Mean age was 70.78  12.34 years (range, 27 to
86 years). 51 cases were CKD stage 3, 31 cases were CKD stage 4, 20 cases
were CKD stage 5. Mean duration of chronic renal insufficiency was
32.7  33.3 months (range, 4 to 120 months). Mean duration of hypertension
was 232.4  174.4 months (range, 4 to 636 months). A low protein diet
(0.6 g/kg.d) and compound a-ketoacid (2.52 g, tid) were given to all pa-
tients. At the same time, the anti-hypertension drugs were not changed dur-
ing the study. After 6 months, statistical analysis was used to compare blood
pressure, PTH and renal function changes before and after treatment.
Results: In 102 cases, total efficiency rate was 83.3%. Mean systolic blood pres-
sure was 163.4  15.8 mmHg before treatment and 137.8  14.8 mmHg after
treatment. Mean diastolic blood pressure was 87.9 12.9 mmHg before treat-
ment and 77.0  9.6 mmHg after treatment (P < 0.01). Mean systolic blood
pressure decreased 25.9  14.8 mmHg and diastolic blood pressure decreased
10.8  9.7 mmHg. There were statistically significant differences. PTH had
markedly decreased after treatment, but there was no statistically significant
differences in renal function before and after treatment.
Conclusion: Low protein diet combining compound a-ketoacid may help to
control hypertension in CKD patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.149
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Risk of Death and Cardiovascular Outcomes in Chronic Kidney Disease
Patients with Chronic Obstructive Pulmonary Disease
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Medical University Hospital, Kaohsiung, Taiwan
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Objective: Chronic obstructive pulmonary disease (COPD) increases all-
cause mortality and cardiovascular (CV) events in general population. How-
ever, rare study investigates the death and CV risks among chronic kidney(OH)2D3 Ca P Ca*P PTH
ml) (mmol/L) (mmol/L) (mmol2/L2) (pg/l)
.11  10.03 2.27  0.19 1.15  0.13 2.61  0.43 33.81  1.47
.78  102.66 2.27  0.17 1.23  0.15 2.79  0.41 38.59  3.29
.12  114.74 2.24  0.22 1.35  0.15) 3.02  0.40 68.14  30.13
.03
30.51)6
2.10  0.21 1.81
 0.13)6
3.80  0.43 225.41
 172.42)6
7.22 209.01 26.44 69.22
01 <0.01 <0.01 <0.01 <0.01
